Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -501 | -141 | -248 | -112 | -4 |
| Other Working Capital | 178 | -12 | -67 | 90 | -3 |
| Other Operating Activity | -68 | -4 | -2 | -1 | 0 |
| Operating Cash Flow | $-391 | $-157 | $-316 | $-23 | $-7 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | 0 | N/A | -45,186 | -45,186 | -3,190 |
| Investing Cash Flow | $N/A | $N/A | $-45,186 | $-45,186 | $-3,190 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 300 | 300 | 300 |
| Common Stock Issued | N/A | N/A | 47,472 | 47,472 | 50 |
| Common Stock Repurchased | N/A | N/A | -25 | -25 | -25 |
| Other Financing Activity | 0 | 0 | -1,766 | -1,766 | 2,883 |
| Financing Cash Flow | $N/A | $N/A | $45,981 | $45,981 | $3,208 |
| Beginning Cash Position | 479 | 479 | N/A | N/A | N/A |
| End Cash Position | 88 | 322 | 479 | 772 | 11 |
| Net Cash Flow | $-391 | $-157 | $479 | $772 | $11 |
| Free Cash Flow | |||||
| Operating Cash Flow | -391 | -157 | -316 | -23 | -7 |
| Free Cash Flow | -391 | -157 | -316 | -23 | -7 |